Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19

• Autori principali: Sergey V Efimov (Autore), Natallia V Matsiyeuskaya (Autore), Olga V Boytsova (Autore), Luydmila Yu Akhieva (Autore), Elena V Kuntsevich (Autore), Anastasia A Troshina (Autore), Elena I Kvasova (Autore), Anton A Tikhonov (Autore), Nadezhda F Khomyakova (Autore), Francisco Harrison (Autore), Jean-François Rossi (Autore), Timothy C Hardman (Autore)
• Natura: Libro
• Pubblicazione: BioExcel Publishing Ltd, 2022-03-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background: Evidence-based therapies used to treat coronavirus disease (COVID-19) remain limited. Azoximer bromide (AZB; Polyoxidonium®) is an immunomodulating molecule frequently used in the Russian Federation. It offers demonstrable therapeutic benefit in upper respiratory tract infections. This s...